Independent Wheelchair Transfers in the Built Environment: How Transfer Setup Impacts Performance Phase 2: Final Report

Number of participants

Phase 1 (n = 120)

Phase 2 (n=63)

Spinal cord injury

54 (45%)

29 (46%)

Multiple sclerosis

10 (8%)

2 (3%)

Cerebral palsy

11 (9%)

3 (4%)

Lower extremity amputation

9 (7%)

8 (12%)

Spina bifida

6 (5%)

4 (6%)

Multiple sclerosis and spinal cord injury

3 (2%)

2 (3%)

Osteogenesis imperfecta

2 (1%)

2 (3%)

Post-polio

2 (1%)

0 (0%)

Traumatic brain injury and spinal cord injury

2 (1%)

0 (0%)

Muscular dystrophy

2 (1%)

1 (1%)

Rheumatoid arthritis

2 (1%)

1 (1%)

Traumatic brain injury

2 (1%)

3 (4%)

Other Category

Phase 1 (n=15)

Phase 2 (n=9)

Traumatic brain injury and lower extremity amputation (n=1)

Stroke (n=2)

Spinal cord injury and lower extremity amputation (n=1)

Ambulatory Dysfunction (n=1)

Osteoporosis (n=1)

Double lower extremity amputation and stroke (n=1)

Stroke (n=1)

Adrenolukodystrophy (n=1)

Adams-Oliver syndrome (n=1)

Cardiac complications (n=1)

Ambulatory Dysfunction (n=1)

Guillian-Barre Syndrom (GBS) (n=1)

Reflex sympathetic dystrophy (n=1)

Side effect of liver disease (n=1)

Spinal stenosis (n=1)

Thrombocytopenia with absent radius (TAR Syndrome) (n=1)

Epidemiral cyst (n=1)

Double lower extremity amputation and stroke (n=1)

Amyotrophic lateral sclerosis (n=1)

Respiratory problems (n=1)

Sarcoidosis (n=1)

Knee replacement complications (n=1)

Hip injury (n=1)